Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
1999-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0e9a550af89085d69a241522394b93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aaa8fd6ba249a66f6a8294ceb151125 |
publicationDate |
2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003170236-A1 |
titleOfInvention |
Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells |
abstract |
The present invention relates to the identification and use of high efficacy vaccine antigens which modulate antigen presenting cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008107641-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828354-B2 |
priorityDate |
1999-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |